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Prophylactic probiotic therapy has shown beneficial effects in an experimental rat model for acute pancre-
atitis on the health status of the animals. Mechanisms by which probiotic therapy interferes with severity of
acute pancreatitis and associated sepsis, however, are poorly understood. The aims of this study were to
identify the probiotic-induced changes in the gut microbiota and to correlate these changes to disease outcome.
Duodenum and ileum samples were obtained from healthy and diseased rats subjected to pancreatitis for 7
days and prophylactically treated with either a multispecies probiotic mixture or a placebo. Intestinal micro-
biota was characterized by terminal-restriction fragment length polymorphism (T-RFLP) analyses of PCR-
amplified 16S rRNA gene fragments. These analyses showed that during acute pancreatitis the host-specific
ileal microbiota was replaced by an “acute pancreatitis-associated microbiota.” This replacement was not
reversed by administration of the probiotic mixture. An increase, however, was observed in the relative
abundance of a novel bacterial phylotype most closely related to Clostridium lituseburense and referred to as
commensal rat ileum bacterium (CRIB). Specific primers targeting the CRIB 16S rRNA gene sequence were
developed to detect this phylotype by quantitative PCR. An ileal abundance of CRIB 16S rRNA genes of more
than 7.5% of the total bacterial 16S rRNA gene pool was correlated with reduced duodenal bacterial over-
growth, reduced bacterial translocation to remote organs, improved pancreas pathology, and reduced proin-
flammatory cytokine levels in plasma. Our current findings and future studies involving this uncharacterized
bacterial phylotype will contribute to unraveling one of the potential mechanisms of probiotic therapy.
Systemic inflammatory response syndrome (SIRS), sepsis,
and multiple organ dysfunction syndrome (MODS) are major
causes of mortality in severely ill patients. The role of the
intestinal microbiota in the initiation and propagation of crit-
ical illness has been increasingly acknowledged during the past
decades. In several disease models it has been demonstrated
that intestinal barrier dysfunction allows gut-derived bacteria
to translocate to extraintestinal organs and cause sepsis and
secondary infectious complications resulting in high mortality
rates (8).
Severe acute pancreatitis is an example of a critical illness
that is characterized by intestinal barrier dysfunction. Acute
pancreatitis usually has a mild and self-limiting clinical
course; however, in about 20 to 30% of the patients it
develops into a serious disease with SIRS and MODS. In
these patients, infection of necrotic pancreatic tissue with
gut-derived bacteria occurs in 30 to 70% of the cases (5).
These infectious complications are frequently the cause of
mortality in patients with acute pancreatitis, with a mortality
rate up to 50% (1, 4, 20).
We have previously shown in an experimental rat model for
acute pancreatitis that prophylactic administration of a mixture
of probiotic bacterial species resulted in reduced bacterial
translocation to the pancreas and other extraintestinal organs,
improved disease outcome, and reduced late mortality of acute
pancreatitis (26). Although the effects of the probiotic therapy
were highly significant, not all treated animals were protected
from the adverse consequences of experimental acute pancre-
atitis. Furthermore, the underlying mechanism(s) by which
probiotics ameliorate the severity of acute pancreatitis is in-
completely understood. In order to get a better insight in the
role of gut microbiota in the process of bacterial translocation
during experimental pancreatitis, a detailed analysis of the
bacterial communities present in the various parts of the in-
testine was made. The aims of this study were to identify the
probiotic-induced changes in the gut microbiota and to corre-
late these changes to disease outcome. As described here,
molecular analysis of intestinal samples of rats treated with
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probiotics has led to a new hypothesis on how probiotics can
improve the clinical course of acute pancreatitis.
MATERIALS AND METHODS
Animals. Male specific-pathogen-free Sprague-Dawley rats, 250 to 350 g (Har-
lan, Horst, The Netherlands), were kept under stable housing conditions with a
12-hour light/dark cycle and free access to water and food (RMH 1110; Hope
Farms, Woerden, The Netherlands) throughout the experiment. All animals
were allowed to adjust to these conditions for 1 week prior to surgery. Rats were
randomized between two experimental groups: 17 rats were included in the
group prophylactically treated with probiotics, and 21 rats were assigned to the
placebo group. Both groups were subjected to the surgical procedures described
below. In addition, six rats which did not receive any surgical intervention or
treatment were used as healthy controls. All animal procedures were performed
in accordance with institutional guidelines and with approval from the institu-
tional animal care committee of the University Medical Center, Utrecht, The
Netherlands.
Probiotics and placebo. The multispecies probiotic mixture consisted of equal
amounts of six different viable, freeze-dried probiotic strains, Bifidobacterium
bifidum (W23), Bifidobacterium animalis subsp. lactis (W52), Lactobacillus aci-
dophilus (W70), Lactobacillus casei (W56), Lactobacillus salivarius (W24), and
Lactococcus lactis (W58), blended in a carrier material consisting of maize starch,
maltodextrins, and a mineral mix (Ecologic 641; Winclove Bio Industries, Am-
sterdam, The Netherlands). The placebo product consisted of carrier material
only. Directly before administration, both the freeze-dried placebo product and
the probiotic mixture were reconstituted in sterile water for 15 min at 37°C. A
single probiotic dose of 1.0 ml contained a total of about 5 109 CFU. Probiotics
or placebo were administered intragastrically through a permanent gastric can-
nula once daily, starting 5 days prior to induction of acute pancreatitis, and twice
daily for 6 days after induction of acute pancreatitis (see Fig. S1 in the supple-
mental material).
Surgical procedures. Surgical procedures were performed as described previ-
ously (26). Briefly, all procedures were performed under general anesthesia using
a combination of 2% isoflurane gas and 0.3 ml 10% buprenorphine intramus-
cularly administered (Temgesic; Reckitt Benckiser Healthcare Ltd., Hull, United
Kingdom). At the start of the experiment, a permanent gastric cannula was fitted
by tunneling a silicone cannula subcutaneously from the abdominal wall to the
back of the animal. The gastric end of the cannula was inserted into the stomach
through a puncture within a purse-string suture on the greater curvature. Ani-
mals were allowed to recover for 3 days prior to the start of daily probiotics or
placebo administration. Five days after starting daily administration of probiotics
or placebo, acute pancreatitis was induced as described previously, with minor
adaptations (21). The common bile duct was clamped, and 0.5 ml sterilized
glycodeoxycholic acid in 10 mM glycylglycine-NaOH-buffered solution (pH 8.0,
37°C; chemicals obtained from Sigma-Aldrich Chemie B.V., Zwijndrecht, The
Netherlands) was infused, after which hepato-duodenal bile flow was restored.
Next, the right jugular vein was cannulated for continuous intravenous infusion
of cerulein (5 g/kg per hour, for 6 h; chemicals obtained from Sigma-Aldrich
Chemie B.V.).
Tissue and fluid samples. Seven days after induction of pancreatitis, surviving
rats were anesthetized to allow aseptic removal of tissue samples and sampling of
peritoneal fluid and blood. After sample collection, rats were euthanized by
blood loss. Mesenteric lymph nodes (MLNs), liver, spleen, pancreas, and duo-
denum were removed for microbiological analysis. After carefully removing all
pancreatic and mesenteric tissue from the proximal duodenum and distal part of
the terminal ileum, sections of approximately 2 cm were excised at both loca-
tions. Both segments were then transferred to a sterile vial, snap-frozen in liquid
nitrogen, and stored at 80°C. A portion of pancreatic tissue was fixed in 4%
formalin and analyzed histopathologically, using standard hematoxylin and eosin
(H&E) staining. The histopathological severity of acute pancreatitis was assessed
based on a scoring system modified from Schmidt et al. (21) as previously
described (26). Several aspects of (peri)pancreatic histopathology were assessed
(peritonitis, edema, ductal pathology, inflammatory infiltrate, acinar cells, acinar
dilatation, and hemorrhagic changes). These aspects were scored on a scale, with
maxima varying from 2 to 5 points per aspect.
All tissue samples were weighed and processed immediately for quantitative
and qualitative culturing of aerobic and anaerobic microorganisms in appropri-
ate media as described previously (26). Tissue samples were homogenized in
cysteine broth and cultured in 10-fold dilution series. The samples were cultured
aerobically on blood agar, MacConkey agar (Gram-negative bacteria), and Co-
lumbia colistin nalidixic acid agar (staphylococci and streptococci), microaero-
bically on Man-Rogosa-Sharpe agar (lactobacilli), and anaerobically on
Schaedler agar. Bacterial counts are presented in CFU/g tissue. Threshold de-
tection level of bacterial growth was 102 CFU/g.
Multiplex cytokine assays. Plasma cytokine levels of interleukin-1 (IL-1),
IL-6, IL-12p70, IL-18, interferon- (IFN-), CXCL1 (growth-related oncogene;
GRO/KC), and CCL2 (monocyte chemoattractant protein-1 [MCP-1]), all from
Linco Research, Inc. (St. Louis, MO), and IL-1, IL-2, IL-10, and tumor necrosis
factor alpha (TNF-), all from Bio-Rad Laboratories (Hercules, CA), were
analyzed using rat cytokine multiplex assays according to the manufacturer’s
instructions.
DNA extraction. Duodenum and ileum samples were taken from the freezer
(20°C), and a 1-cm section from the center of the sample was excised on a
sterile field. A longitudinal incision over the full 1-cm section was made, and the
sample was left to thaw on a piece of sterile aluminum foil placed directly on a
cooled metal plate at 4°C. After thawing, the intestinal content, including the
mucosa, was scraped off with the back of a sterile surgical blade and collected in
a 2-ml screw-cap tube containing a buffer solution of 6 M guanidine thiocyanate,
0.6% Tween 20 (vol/vol), 10 mM EDTA, 50 mM Tris-HCl (pH 6.5), and 2 g of
zirconia beads (0.1 mM; Biospec, Bartlesville, OK). For DNA extraction from
pure bacterial cultures and the complete probiotic mixture, approximately 108
CFU was used. Cells were physically disrupted by shaking for 4 min in a Mini-
Beadbeater-96 (Biospec), followed by heating for 5 min at 90°C. Samples were
centrifuged for 1 min at 10,000  g, and 200 l of the supernatant was subse-
quently used for DNA isolation. DNA isolation was performed as described
previously (7), except for omitting the final washing step with acetone.
T-RFLP analysis. Terminal-restriction fragment length polymorphism (T-
RFLP) analysis was performed as described previously (15). For PCR amplifi-
cation of 16S rRNA gene fragments, the universal primers 8F and 926R (Table
1), with fluorescent dyes 6-FAM and NED, respectively, at the 5	 end, were used.
Reaction mixtures (15 l) contained PCR buffer (Applied Biosystems, Foster
City, CA), 62.5 M each deoxynucleoside triphosphate (dNTP; Applied Biosys-
tems), 1.5 mM MgCl2, a 0.5 M concentration of each primer, 0.5 U of Taq DNA
polymerase (Promega, Madison, WI), and 1 l of DNA sample. DNA amplifi-
cation was performed with a 9700 thermal cycler (Perkin-Elmer, Norwalk, CT)
using the following program: 94°C for 5 min, followed by 35 cycles of 30 s at 94°C,
45 s at 56°C, and 2 min at 72°C, and a final extension for 5 min at 72°C. PCR
products were digested with MspI and HinP1I, with both enzymes in the same
reaction (New England BioLabs, Ipswich, MA). The resulting fragments were
size separated using an ABI 3100 genetic analyzer (Applied Biosystems)
equipped with 36-cm capillaries using POP4 gel matrix. A custom size standard
TABLE 1. Primers and their targets used in this study
Primer Primer sequence (5	–3	) Target Reference
8F AGA GTT TGA TCC TGG CTC (AG) Universal 16S rRNA gene 14
926R CCG TCA ATT CCT TTR AGT TT Universal 16S rRNA gene 17
T7 TAA TAC GAC TCA CTA TAG G pGEM-T vector specific Promega
SP6 GAT TTA GGT GAC ACT ATA G pGEM-T vector specific Promega
519R GWA TTA CCG CGG CKG CTG Universal 16S rRNA gene 14
533F GTG CCA GCA GCC GCG GTA A Universal 16S rRNA gene 27
Bact1369F CGG TGA ATA CGT TCY CGG Universal 16S rRNA gene 24
Prok1492R GGW TAC CTT GTT ACG ACT T Universal 16S rRNA gene 24
CRIB-61F GTC GAG CGA TTT ACT TCG GTA CRIB-specific 16S rRNA gene This study
CRIB-235R GGG TCC ATC CTG TAC CGC AAA CRIB-specific 16S rRNA gene This study
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with ROX-labeled fragments, MapMarker 30–1,000 (Bioventures, Murfrees-
boro, TN), was added to each sample prior to electrophoresis for accurate sizing
of terminal-restriction fragments (T-RFs). After electrophoresis, sizes of fluo-
rescently labeled T-RFs were determined using GeneScan software (Applied
Biosystems).
Observed T-RFs were assigned to microbial taxa using the MCPC database
(Dr. Van Haeringen Laboratorium B.V., Wageningen, The Netherlands), which
was built using in silico T-RF predictions from data that were extracted from
prokaryote sections of the EMBL sequence database (release 82, March 2005)
using Patscan (9). For each of the extracted sequences the T-RF size using the
aforementioned combination of primers and restriction enzymes was calculated
for both primers, and calculated values were validated for a number of pure
cultures, including Escherichia coli, Clostridium perfringens, and Staphylococcus
aureus (data not shown). The relative peak intensity of each T-RF (referred to as
relative abundance) was defined as the height of a specific peak as a percentage
of the total sum of all peak heights for a given sample. Relative abundance was
calculated for all T-RFs between 50 and 600 bp long and with peak heights of
50 fluorescence units (FU), which was well above the background noise level
(10 to 20 FU) of nontemplate control reactions. This procedure was followed for
both primers; the data obtained with primer 8F were used in the figures.
Identification of the 16S rRNA gene sequence of CRIB. PCR mixtures (50 l)
were prepared using Taq DNA polymerase kit from Invitrogen (Gaithersburg,
MD) and contained 0.5 l of Taq DNA polymerase (1.25 U), 20 mM Tris-HCl
(pH 8.5), 50 mM KCl, 3.0 mM MgCl2, 5 pmol of the primers 8F and 926R (Table
1), 200 M each dNTP, and 1 l of template DNA. Amplification was performed
with a T1 thermocycler (Whatman Biometra, Go¨ttingen, Germany) using the
following program: 94°C for 5 min, followed by 35 cycles of 30 s at 94°C, 20 s at
56°C, and 40 s at 68°C, and a final extension for 7 min at 68°C. Aliquots (5 l)
were analyzed by agarose electrophoresis to check for product size and quantity.
Products were purified with the QIAquick PCR purification kit (Westburg,
Leusden, The Netherlands) according to the manufacturer’s instructions, and
cloned into the pGEM-T easy vector system (Promega) using competent E. coli
JM109 as a host. Colonies of ampicillin-resistant transformants were transferred
with a sterile toothpick to 15 l of Tris-EDTA buffer and boiled for 15 min at
95°C. PCR was performed using vector-specific primers T7 and SP6 (Table 1) to
check the sizes of the inserts using the cell lysate as a template. PCR products of

0.95 kb were purified as described above and digested at 37°C for 90 min with
CfoI, which is an isoschizomer of HinP1I, and MspI (Boehringer, Mannheim,
Germany). One clone, containing an insert yielding a fragment of approximately
450 bp after restriction analysis, was grown in Luria broth liquid medium (5 ml)
with ampicillin (100 g/ml) and used for further 16S rRNA gene sequence
analysis. Plasmid DNA was isolated using the Wizard Plus purification system
(Promega) and sequenced by using the Sequenase (T7) sequencing kit (Amer-
sham Life Sciences, Slough, United Kingdom) according to the manufacturer’s
specifications using primers T7, SP6, 519R, and 533F (Table 1) labeled with
IRD-800. Sequences were automatically analyzed on a LiCor DNA Sequencer
4000L (LiCor, Lincoln, NE) and manually assembled.
Phylogenetic analysis and primer design. The CRIB 16S rRNA gene sequence
was aligned with published 16S rRNA sequences (see Fig. S2 in the supplemental
material) using the ARB software package and release 90 of the ARB-SILVA
reference database (16, 18). Different primer sets were developed using the
ProbeDesign and ProbeMatch functions in ARB and were tested for specificity
by conventional PCR. The primer set CRIB-61F/CRIB-235R (Table 1) was
further tested by qPCR. For phylogenetic analyses as presented here, the se-
quence was realigned using the SINA WebAligner (http://www.arb-silva.de) and
compared to published sequences using ARB-Silva release 102.
qPCR analysis. Quantitative PCR (qPCR) was performed using the iQ5 Real-
Time PCR detection system (Bio-Rad). Reaction mixtures (25 l) contained 12.5
l iQ SYBR green supermix (Bio-Rad), 0.2 M each primer, and 5 l of
template DNA. All reactions were performed in triplicate. Standard curves were
generated from a dilution series of 16S rRNA gene fragments amplified from the
target sequence (108 to 100 copies/l). The universal primer set Bact1369/
Prok1492 (Table 1) was used for quantification of total bacterial 16S rRNA gene
copies using the following program: 3 min at 95°C, followed by 40 cycles of 15 s
at 95°C, 30 s at 56°C, and 30 s at 72°C. Primers CRIB-61F/CRIB-235R were used
to determine the relative abundance of CRIB 16S rRNA gene copies in the
samples. Amplification conditions included 3 min at 95°C, followed by 40 cycles
of 20 s at 95°C and 1 min at 68°C. Gradient PCR was initially used to determine
the optimal annealing temperature, with amplification efficiency, range of lin-
earity, and lowest detectable concentration as criteria. The predicted specificity
of the CRIB-specific qPCR primer set was confirmed using nearly full-length 16S
rRNA gene amplicons that were obtained, using primer pair 8F/Prok1492 (Table
1), from genomic DNA of closely related bacterial species: Clostridium litusebu-
rense (DSM 797T), Clostridium irregulare (DSM 2635T), Clostridium hiranonis
(DSM 13275T), and Clostridium bartlettii (DSM 16795T).
Relative abundance of CRIB was calculated by dividing CRIB 16S rRNA
gene copies amplified using the primer set CRIB-61F/CRIB-235R by total
16S rRNA gene copies amplified using the primer set Bact1369/Prok1492 per
l of isolated DNA.
Statistical analysis. T-RFLP profiles were compared by visual inspection and
principal component analysis (PCA) using VHL analysis software (Dr. Van
Haeringen Laboratorium B.V.) that was custom built in collaboration with Dali-
con B.V. (Wageningen, The Netherlands) using IDL (RSI, Boulder, CO). The
number of T-RFs is presented as mean  standard error of the mean (SEM).
The nonparametric Kruskal-Wallis test, followed by post hoc Mann-Whitney U
tests with Bonferroni correction, was used to test for statistical differences in the
relative abundance of CRIB between the different independent treatment
groups. The intraclass correlation coefficient (ICC) was calculated to compare
the T-RFLP to qPCR analysis. The correlation between two variables was de-
scribed with Spearman’s rank correlation coefficients and corresponding P
values. Differences in bacterial counts, histopathological scores, and plasma
cytokine levels between different groups of animals were analyzed using the
Mann-Whitney U test. Differences with P values of 0.05 were considered
statistically significant.
Nucleotide sequence accession number. The partial 16S rRNA gene sequence
of CRIB has been submitted to the GenBank/EMBL/DBBJ databases under
accession number HQ224563.
RESULTS
Acute pancreatitis induces changes in duodenal and ileal
microbiota. To study the changes in duodenal and ileal micro-
biota as result of acute pancreatitis, duodenal and ileal samples
were studied by T-RFLP analysis of PCR-amplified 16S rRNA
gene fragments.
Previously we have demonstrated that there was a small
increase in the total bacterial counts in the duodenum and a
significant increase in culturable opportunistic pathogens 7
days after the induction of acute pancreatitis (26). In the pres-
ent study, T-RFLP analysis of duodenal microbiota demon-
strated that the number of T-RFs almost doubled in the dis-
eased animals (7 days after induction of acute pancreatitis)
compared to healthy control animals (25 3.5 versus 41 8.4,
healthy control versus placebo, respectively). T-RFLP analysis
of the bacterial communities in the terminal ileum, however,
showed that induction of acute pancreatitis resulted in only a
modest increase in the number of T-RFs in diseased animals
compared to healthy controls (60.3  7.2 versus 69.0  7.5,
healthy control versus placebo, respectively).
The composition of the ileal microbiota, as evaluated by
PCA, was altered in the diseased animals compared to the
healthy controls. Each healthy rat displayed a unique micro-
biota fingerprint, visible as a characteristic scattering of the
samples in the two-dimensional space of the first principal
components (Fig. 1). In contrast, the samples of the diseased
animals, with one exception, show a strong clustering, demon-
strating that the diseased animals apparently acquired a rather
uniform “acute pancreatitis-associated microbiota” indepen-
dent of which treatment was administered.
Probiotics stimulate a not previously described bacterium in
the terminal ileum. T-RFLP analysis demonstrated that T-RFs
of the length predicted for those of the probiotic bacteria could
also be detected in placebo-treated animals, indicating that the
endogenous microbiota shares similar T-RFs with the probi-
otic bacteria (see Fig. S3 and S4 in the supplemental material).
Probiotic-induced changes in the duodenal microbiota could
not be detected based on T-RFLP analysis (Fig. S3). In con-
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trast, in the ileal samples a significant increase of an unknown
bacterial phylotype (T-RF 457 bp, primer 8F, MspI and
HinP1I digested) was observed in the probiotic-treated ani-
mals compared to the placebo-treated animals (Fig. 2 and Fig.
S4). This T-RF could also be detected in a number of healthy
control animals. It could be excluded that this bacterial phylo-
type was administered inadvertently, because it was absent in
both the multispecies probiotic mixture and the carrier mate-
rial (placebo) (data not shown).
In order to further characterize this phylotype, a 16S rRNA
gene clone library was generated from ileal DNA samples
showing the 457-bp T-RF. Clones were screened by RF anal-
ysis using enzymes recognizing the same restriction sites as
those applied for T-RFLP analysis, and a representative clone
containing an insert leading to a fragment of approximately
450 bp was selected for further sequence analysis. The cloned
16S rRNA gene fragment, yielding a predicted T-RF of 457 bp,
showed less than 97% sequence identity to the 16S rRNA gene
sequences of bacterial isolates (Table 2), suggesting that it
might represent a not-previously described bacterial species,
which in the following is referred to as “commensal rat ileum
bacterium” (CRIB). Higher sequence identities were observed
with environmental sequences mostly retrieved from mamma-
lian intestinal samples, including mouse and human (Fig. 3).
Based on the 16S rRNA gene sequence of the CRIB clone,
a primer set was designed for the specific quantitative detec-
tion of CRIB in environmental samples by qPCR. In order to
demonstrate that these primers indeed specifically detect the
same 16S rRNA gene sequences that give rise to the 457-bp
T-RF, qPCR was performed on the ileal DNA samples and the
results were compared to the T-RFLP results. An overall good
agreement between the two techniques for calculation of the
relative abundance of CRIB was demonstrated by the highly
significant correlation between the two data sets (ICC  0.893,
P  0.001; see Fig. S5 in the supplemental material).
Relative ileal abundance of CRIB is associated with de-
creased disease severity. Different measures of disease out-
come were analyzed in order to assess disease severity, includ-
ing duodenal bacterial overgrowth, bacterial translocation to
remote organs, and pancreas pathology. The relative abun-
dance of CRIB in the ileum of the diseased rats was inversely
correlated with the degree of bacterial overgrowth in the duo-
denum (Fig. 4a). Total bacterial counts were lower in the
duodenum of animals with high relative ileal abundance of
CRIB. In addition, bacterial infection of the MLNs (Fig. 4b),
as well as the liver, spleen, and pancreas (see Fig. S6 in the
supplemental material), was also inversely correlated with the
relative ileal abundance of CRIB. Furthermore, histopatholog-
ical evaluation of pancreatic tissue obtained 7 days after the
FIG. 1. Correlations between the T-RFLP profiles obtained from
the ileal samples mapped onto the first and third principal components
of PCA. Healthy rats are indicated with circles. Diseased rats are
indicated with asterisks (placebo-treated animals) or squares (probi-
otic-treated animals).
FIG. 2. Effect of pancreatitis and treatment with either placebo or
the probiotic mixture on the relative ileal abundance of T-RF 457,
corresponding to the as yet uncharacterized bacterial phylotype re-
ferred to as CRIB. Indicated are healthy control (white bar) and
diseased animals, treated either with placebo (light gray bar) or the
probiotic mixture (dark gray bar), respectively. Box-and-whisker dia-
grams represent median with interquartile range (boxes) and minimum
and maximum nonoutlier values (whiskers). An asterisk indicates a
significant difference (P  0.05).
TABLE 2. 16S rRNA gene sequence identities of the CRIB clone
with published sequences
GenBank
accession no. Description % identity
a
EU089965 Clostridium maritimum strain G12 96%
EU089964 Clostridium ruminantium strain LA1 96%
M59107 Clostridium lituseburense (DSM 797) 96%
AB538434 Clostridium bifermentans (JCM 7832) 95%
AB550230 Clostridium sordellii (JCM 3814) 94%
AF320283 Clostridium bifermentans (DSM 13560) 94%
AB075771 Clostridium sordellii (ATCC 9714) 94%
NR_027573 Clostridium bartlettii (DSM 16795) 94%
X73451 Clostridium ghonii (NCIMB 10636) 94%
X73450 Clostridium difficile (DSM 11209) 94%
NR_029249 Clostridium irregulare strain 6VI
(DSM 2635)
93%
NR_028611 Clostridium hiranonis strain TO-931
(DSM 13275)
92%
a The percentage of identity was determined by comparison of the partial 16S
rRNA gene sequence of CRIB with sequences present in the database using the
BLAST tool from NCBI.
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induction of acute pancreatitis demonstrated that pancreas
pathology was significantly and inversely correlated with the
relative ileal abundance of CRIB (Fig. 4c). Acinar cell pathol-
ogy and inflammatory cell infiltrate were the aspects which
contributed most to this correlation (see Fig. S6 in the supple-
mental material). It should be noted that the relative ileal
numbers of the administered probiotic strains, or endogenous
strains with identical T-RFs, did not correlate with the clinical
and histological severity of the pancreatitis.
The data presented above suggest that the clinical effects
of intervention with probiotics are mediated by CRIB. In
order to substantiate this association, the diseased animals
were divided into two groups with either a low (7.5%) or
a high (7.5%) relative ileal abundance of CRIB, based on
their average relative ileal abundance of CRIB as deter-
mined by qPCR analysis. A significantly lower total number
of duodenal bacteria was detected in the animals with
7.5% CRIB compared to the animals with 7.5% CRIB
(P  0.05). In addition, a relative abundance of CRIB above
7.5% was also significantly correlated (P  0.05) with less
bacterial infection of the MLNs and lower total histopatho-
logical scores of the pancreas.
FIG. 3. Neighbor-joining tree based on the 16S rRNA gene sequence of CRIB and other related clostridia. E. coli was included as an outgroup.
Alignment and phylogenetic analysis were performed with the ARB software (16). The tree was calculated for E. coli positions 55 to 926. The
reference bar indicates 10% sequence divergence. GenBank accession numbers are given in parentheses.
FIG. 4. Associations between different measures of disease outcome and the relative ileal abundance of CRIB in diseased rats after 7 days of
acute pancreatitis. Animals were treated with either placebo (gray dots) or probiotics (squares). Indicated are total bacterial counts in the
duodenum (a), bacterial translocation to the MLNs (b), and total pathology of the pancreas (c). The relative abundance of CRIB was determined
by qPCR analysis. Bacterial counts are expressed in log10 CFU per gram of sample. Pearson’s correlation coefficients are provided, with
corresponding P values. The dotted lines indicate the divisions between the samples with a low (7.5%) or high (7.5%) relative ileal abundance
of CRIB (7.5%).
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Relative ileal abundance of CRIB is associated with altered
cytokine levels during acute pancreatitis. To determine the
possible association between high relative abundance of CRIB
in the ileum and cytokine plasma levels, a cytokine multiplex
assay was performed on the plasma samples obtained 7 days
after induction of acute pancreatitis. In a previous study, we
identified high plasma levels of IL-1, IL-6, IL-10, CXCL1,
and TNF- as strong predictors of mortality and bacteremia
during the course of acute pancreatitis in rats, and it was found
that treatment with a multispecies probiotic mixture causes a
mild reduction of these cytokines (data not shown). In line with
these observations, the animals with high relative ileal abun-
dance of CRIB (7.5%) showed significantly lower plasma
levels of IL-1 and TNF- and a tendency to reduced levels of
IL-10 and CXCL1 (Fig. 5). In addition, elevated plasma levels
of IL-18, a proinflammatory cytokine, which is significantly
increased in acute pancreatitis patients with local or systemic
complications (19), were detected only in animals having a low
relative ileal abundance of CRIB (7.5%; Fig. 5b).
DISCUSSION
A not previously described bacterial phylotype (CRIB) was
identified in this study to be associated with reduced severity of
pancreatitis and associated sepsis. A higher than average rel-
ative ileal abundance of CRIB (i.e., 7.5%) was significantly
correlated with decreased duodenal bacterial overgrowth, re-
duced bacterial translocation to remote organs, reduced infec-
tion of pancreatic necrosis, and improved pancreas histology.
In addition, high relative abundance of this bacterial phylotype
was associated with less severe immune responses during acute
pancreatitis as demonstrated by lower plasma levels of proin-
flammatory cytokines. Moreover, we demonstrated that there
is an association between the presence of CRIB in the ileum of
rats and the administration of a multispecies probiotic mixture.
Together, these results suggest that effects of this multispecies
probiotic mixture (Ecologic 641) are mediated by stimulation
of a not previously described gut commensal bacterium
(CRIB), which protects the host from severe sepsis. The bac-
terial species most closely related to this not previously de-
scribed bacterial phylotype is Clostridium lituseburense. For the
detection of this bacterial phylotype, a specific and quantitative
PCR (qPCR) assay was developed using 16S rRNA gene-
targeted primers. This qPCR can be used in future studies to
detect this phylotype in clinically relevant samples.
Dysbiosis of the small intestinal microbiota is often seen in
critically ill patients and can be a cause of the development of
sepsis. For example, a low level of intestinal bacterial over-
growth can be detected in patients with hepatic cirrhosis and is
associated with systemic endotoxemia (3, 28). In the case of
acute pancreatitis, the occurrence of small intestinal bacterial
overgrowth is a pathological event during the course of acute
pancreatitis due to impaired intestinal motility and is quanti-
FIG. 5. Effect of low (7.5%; white bars) or high (7.5%; gray bars) relative ileal abundance of CRIB in diseased rats on plasma cytokine levels
of IL-1 (a), IL-18 (b), TNF- (c), IL-10 (d), CXCL1 (e), and IL-6 (f). The relative abundance of CRIB was determined by qPCR analysis.
Box-and-whisker diagrams represent median with interquartile range (boxes) and minimum and maximum nonoutlier values (whiskers). Significant
differences: *, P  0.05; † , P  0.10.
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tatively and qualitatively correlated with bacterial transloca-
tion and infection of pancreatic necrosis (25, 26). In addition,
it has recently been demonstrated in a rat model that during
acute pancreatitis bacterial translocation occurs from the small
intestine rather than from the colon (10). The duodenal bac-
terial counts found in this study confirm our previous findings
that acute pancreatitis leads to duodenal bacterial overgrowth.
Despite the occurrence of bacterial overgrowth in the duode-
num, there was no change in composition of the duodenal
microbiota. In contrast, the composition of the ileal microbiota
was considerably changed upon induction of acute pancreatitis.
PCA revealed that each healthy rat displayed a unique ileal
microbiota fingerprint, as previously observed for ileal micro-
biota of healthy humans (6). In contrast, increased similarity of
the T-RFLP profiles of diseased animals indicated that these
animals acquired an “acute pancreatitis-associated microbi-
ota” independent of which treatment was deployed. Appar-
ently, pancreatitis induces such a strong modification of the
ileal microbiota that the unique individual microbial inhabit-
ants are replaced by other, potentially pathogenic bacteria.
Previous studies have demonstrated that although the effects
of this specific probiotic mixture were highly significant, not all
probiotic-treated animals were protected from the adverse ef-
fects of experimental acute pancreatitis (26). Here we show
that one bacterial phylotype (referred to as CRIB) was signif-
icantly more abundant in the ileum of animals prophylactically
treated with the probiotic mixture than in that of the placebo-
treated animals. However, both T-RFLP and qPCR analysis
showed high interindividual variation in the relative abundance
of CRIB in the terminal ileum, which suggests that this bacte-
rium is not an equally dominant member of the normal micro-
biota in every animal. This might explain why the administra-
tion of the multispecies probiotic mixture could not prevent
pancreatitis-associated infectious complications in every ani-
mal. In fact, in animals that reacted poorly to probiotic treat-
ment (e.g., the animals with high pancreatic bacterial counts),
CRIB was present only in relatively low numbers (7.5%).
The chosen threshold value was set at 7.5%, based on the
average relative abundance of CRIB in the total group of
diseased animals. The relatively small sample size prevented a
more accurate estimate of the threshold by ROC analysis. Still,
the data point toward an important role of CRIB in the effec-
tiveness of probiotic treatment. As the present study had not
been designed to provide mechanistic insight in this associa-
tion, it is currently unknown if and how probiotic administra-
tion can lead to an increase in relative abundance of CRIB, as
well as a decrease in disease severity. The causality of the
observed association between CRIB and protection against
severe sepsis will be addressed in future experiments.
The terminal ileum is the main site for interaction of com-
mensal microbiota with the host immune system. This is re-
flected by the fact that the Peyer’s patches, organized lymphoid
tissue important for immune surveillance and initiating of im-
mune responses in the gut, are mainly located in the ileum
(13). In our study we demonstrated that CRIB can be a dom-
inant member of the ileal microbiota in rats, reaching up to
20% of the total microbiota in some animals. The mechanisms
by which CRIB confers protective effects may include modu-
lation of the mucosal immune system. This is suggested by the
observation that the relative abundance of CRIB was corre-
lated with altered plasma cytokine levels during acute pancre-
atitis.
Recently, important roles in counterbalancing dysbiosis and
regulation of immune responses have been suggested for sev-
eral specific members of the gut microbiota. Faecalibacterium
prausnitzii has been described to have anti-inflammatory prop-
erties in both in vitro and in vivo models (22), and underrep-
resentation of this bacterium in the gut microbiota was sug-
gested to be involved in IBD pathogenesis in both animals and
humans (23). Furthermore, segmented filamentous bacteria
(SFB) were shown to have a crucial role in maturation of T cell
responses in the gut (11, 12). Faecalibacterium prausnitzii and
SFB are members of the same taxonomic class as CRIB, the
Clostridia; however, they belong to different subgroups (Fig. 3).
In addition, a recent study has demonstrated a significant in-
duction of colonic regulatory T cells as result of the coloniza-
tion by a specific mix of indigenous Clostridium species in a
mouse experiment (2). In that study, early inoculation of these
Clostridium species resulted in the amelioration of the effects
of experimental colitis and a lower IgE production level. Al-
together, these studies demonstrate that specific members of
the Clostridia can have health-promoting effects.
We anticipate that the findings reported here will be of key
importance in unraveling one of the potential mechanisms of
probiotic action and fostering a further understanding of the
relation between gut microbiota and the host. Future experi-
ments, including efforts toward the isolation of CRIB, will
evaluate whether CRIB also plays a role in human disease.
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